Výsledky vyhledávání - "E. A. Privalova"

Akademický článek

Vascular Remodeling Markers in Patients with Essential Arterial Hypertension Depending on Presence of Type 2 Diabetes Mellitus

Autor: Yu. A. Danilogorskaya, E. A. Zheleznykh, E. A. Privalova, Yu. N. Belenkov, A. A. Shchendrigina, M. V. Kozhevnikova, G. A. Shakaryants, V. Y. Zektser, A. S. Lishuta, I. S. Ilgisonis

Publikováno v: Рациональная фармакотерапия в кардиологии, Vol 15, Iss 3, Pp 328-334 (2019)

Aim. To study some vascular remodeling markers in hypertensive patients depending on the presence of type 2 diabetes mellitus.Material and methods. The study included patients with essential hypertension 1-2 degrees of increase in blood pressure with

Externí odkaz: https://doaj.org/article/8599c7d6eda940c19466709b6e680653

Zobrazit plný text záznamu

Correlation between the level of C-reactive protein and the parameters of the functional status of the left atrium in patients with lymphoproliferative diseases against the background of chemotherapy

Autor: E. Yu. Salakheeva, A. A. Shchendrygina, I. Ya. Sokolova, K. A. Zhbanov, S. A. Tsatsurova, N. I. Kanevskiy, Yu. N. Muzychenko, S. A. Kardanova, V. O. Stebakova, E. V. Privalova, T. Yu. Kulagina, O. A. Bulkina, I. S. Ilgisonis, Yu. N. Belenkov

Publikováno v: Clinical Medicine (Russian Journal). 101:55-62

Aim. To assess the dynamics of functional changes in the left atrium (LA) in patients with lymphoproliferative diseases (LPD) before polychemotherapy (PCT), during treatment, after 6 courses of treatment, and the frequency of supraventricular arrhyth

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cbfbe0e4189f3de8a38bee74e4d78f83
https://doi.org/10.30629/0023-2149-2023-101-1-55-62

Zobrazit plný text záznamu

Inflammatory Activity in Patients with Obstructive and Non-obstructive Coronary Artery Disease

Autor: N. N. Pakhtusov, A. O. Yusupova, A. S. Lishuta, O. A. Slepova, E. V. Privalova, Yu. N. Belenkov

Publikováno v: Rational Pharmacotherapy in Cardiology. 19:26-33

Aim. To study the levels of pro-inflammatory biomarkers in patients with obstructive and non-obstructive coronary artery disease (CAD), to identify possible differences for diagnosing the degree of coronary obstruction.Material and methods. The obser

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7e8cf545787a3875b0e1b07fb18fc4df
https://doi.org/10.20996/1819-6446-2023-01-09

Zobrazit plný text záznamu

Evaluation of Fibrosis Markers as a Potential Method for Diagnosing Non-Obstructive Coronary Artery Disease in Patients with Stable Coronary Artery Disease

Autor: N. N. Pakhtusov, A. O. Yusupova, K. A. Zhbanov, A. A. Shchedrygina, E. V. Privalova, Yu. N. Belenkov

Publikováno v: Rational Pharmacotherapy in Cardiology. 18:630-637

Aim. To study the levels of fibrosis markers in patients with stable coronary artery disease (CAD) and various types of coronary artery (CA) lesions (obstructive and non-obstructive), to identify possible differences for diagnosing the types of coron

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6f69f2225d5a247fc10e2969fb66dd2a
https://doi.org/10.20996/1819-6446-2022-11-01

Zobrazit plný text záznamu

The Effect of COVID-19 on Long-Term Cardiac Function in Patients With Chronic Heart Failure

Autor: A. A. Ageev, M. V. Kozhevnikova, A. V. Emelyanov, A. V. Krivova, Yu. F. Shumskaya, L. M. Musaeva, L. V. Popova, Yu. I. Naymann, G. B. Abdullaeva, E. V. Privalova, Yu. N. Belenkov

Publikováno v: Kardiologiia. 62:23-29

Aim To evaluate functional changes in the heart in the long-term following COVID-19 in patients with chronic heart failure (CHF).Material and methods Case reports of 54 patients aged 69.1±9.7 years who had COVID-19 from January 2021 through January

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::59ded95103aba1c6b00b26187d592e9c
https://doi.org/10.18087/cardio.2022.12.n2265

Zobrazit plný text záznamu

Comparative analysis of tryptophan and downstream metabolites of the kynurenine and serotonin pathways in patients with arterial hypertension and coronary artery disease

Autor: M. V. Kozhevnikova, A. V. Krivova, E. O. Korobkova, A. A. Ageev, K. M. Shestakova, N. E. Moskaleva, S. A. Appolonova, E. V. Privalova, Yu. N. Belenkov

Publikováno v: Kardiologiia. 62:40-48

Aim To compare serum concentrations of tryptophane (Trp) and its metabolites in subjects with no cardiovascular disease (CVD) and patients with СVD, including arterial hypertension (AH) and ischemic heart disease (IHD).Material and methods This stud

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3c1b3608ed989bc5463cb8cadfc3818
https://doi.org/10.18087/cardio.2022.11.n2283

Zobrazit plný text záznamu

The Prognostic Value of Neuregulin-1β in Heart Failure Patients With Preserved Ejection Fraction

Autor: K. A. Zhbanov, A. A. Shchendrygina, E. Yu. Salakheeva, I. Ya. Sokolova, A. A. Agadzhanyan, E. A. Zheleznykh, V. Yu. Zektser, E. V. Privalova, Yu. N. Belenkov

Publikováno v: Kardiologiia. 62:3-8

Aim To determine the neuregulin-1β concentration in patients with chronic heart failure with preserved ejection fraction (HFpEF) and the association of this biomarker with the functional status of patients, echocardiographic parameters of the struct

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcc8060fb0d33907874dc0485c00eda8
https://doi.org/10.18087/cardio.2022.9.n2241

Zobrazit plný text záznamu

Left Atrium Involvement in Lymphoma Patients: Single Center Observational Study

Autor: E. Yu. Salakheeva, I. Ya. Sokolova, O. V. Lyapidevskaya, K. A. Zhbanov, S. A. Tsatsurova, N. I. Kanevskiy, V. O. Stebakova, E. V. Privalova, I. S. Ilgisonis, Yu. N. Belenkov, A. A. Shchendrygina

Publikováno v: Rational Pharmacotherapy in Cardiology. 18:385-392

Aim. To assess the structure and performance of left atrium (LA) before and after 3 cycles of anticancer treatment in lymphoma patients, as well as the incidences of supraventricular arrhythmia (SVA) and the levels of biomarkers of inflammation.Mater

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b0f5d90c70a84b28a91ea4abaec10537
https://doi.org/10.20996/1819-6446-2022-08-02

Zobrazit plný text záznamu

The Effect of Enhanced External Counterpulsation on the Vascular State, Indicators of Glycemic Control and Quality of Life in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus

Autor: O. A. Slepova, A. S. Lishuta, E. Yu. Vasiltsova, E. V. Privalova, Yu. N. Belenkov

Publikováno v: Rational Pharmacotherapy in Cardiology. 18:274-281

Aim. To study the effect of enhanced external counterpulsation (EECP) on the functional status, quality of life, structural and functional state of the vascular bed, and markers of glycemic control in patients with coronary artery disease (CAD) and t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f00337a47e39103edae1649af92aeabe
https://doi.org/10.20996/1819-6446-2022-06-04

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání